col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
Bentham Science: Combinatorial Chemistry & High Throughput Screening
  original article Date Title Authors   All Authors
1 [GO] 2022―May―11 Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus: In Silico Study Immunomodulatory Drugs Dikdik Kurnia, Ika Wiani, Achmad Zainuddin, Devi Windaryanti, Christine Sondang Gabriel
2 [GO] 2022―Apr―28 Neglected Tropical Diseases (NTDs) and COVID-19 Pandemic in Africa: Special Focus on Control Strategies Abdullahi Tunde Aborode, Emmanuel Adebowale Fajemisin, Emmanuel Ademola Aiyenuro, Muhammed Alakitan, Matthew Olaide Ariwoola, Jegede Oluwatoyin Imisioluwa, et al. (+2)
3 [GO] 2022―Apr―25 Can the Written Word Fuel Pharmaceutical Innovation? Part 1. an emerging vista from von Economo to COVID-19 Gerald H. Lushington, Mary I. Zgurzynski
4 [GO] 2022―Apr―18 Favipiravir in SARS-CoV-2 infection: Is it Worthwhile? Gaber El-Saber Batiha, Mohamed Moubarak, Hazem M. Shaheen, Ali Muhammad Zakariya, Ibe Michael Usman, Abdur Rauf, et al. (+6)
5 [GO] 2022―Mar―16 Covid-19 Vaccines available in India Mohammad Mukim, Pratishtha Sharma, Mohsina F.P, Faheem I.P, Rajiv Kukkar, Rakesh Patel
6 [GO] 2022―Mar―16 Crosstalk between SARS-CoV-2 Infection and Type II Diabetes Asim Azhar, Wajihul Hasan Khan, Khaled Al-hosaini, Qamar Zia, Mohammad Amjad Kamal
7 [GO] 2022―Mar―01 Therapeutic mechanism of Xiaoqinglong decoction against COVID-19 based on network pharmacology and molecular docking technology Hai-Li Li, Jian-Peng Zhou, Jing-Min Deng
8 [GO] 2022―Feb―10 Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking Abdul Nazeer K.A.
9 [GO] 2022―Jan―28 Natural products against COVID-19 inflammation: a mini-review Simone Mendes Lopes, Herbert Igor Rodrigues de Medeiros, Marcus Tullius Scotti, Luciana Scotti
10 [GO] 2022―Jan―13 Computational Chemistry in the Fight Against SARS-CoV-2. Abbas Khan, Dong-Qing Wei
11 [GO] 2021―Dec―01 Can We Use mTOR Inhibitors for COVID-19 Therapy? Ina Y. Aneva, Solomon Habtemariam, Maciej Banach, Parames C. Sil, Kasturi Sarkar, Adeleh Sahebnasagh, et al. (+3)
12 [GO] 2021―Nov―23 Potential Papain-like Protease Inhibitors against COVID-19: A Comprehensive In Silico Based Review Neetu Agrawal, Shilpi Pathak, Ahsas Goyal
13 [GO] 2021―Sep―17 Polyphenolic Natural Products Active In Silico against SARS-CoV-2 Spike Receptor Binding Domains and Non-Structural Proteins - A Review Mark Tristan Quimque, Kin Israel Notarte, Xela Amor Adviento, Mikhail Harvey Cabunoc, Von Novi de Leon, Felippe Steven Louis delos Reyes, et al. (+10)
14 [GO] 2021―Aug―12 COVID-19: Finally on wane, with reduced lethality Deepak Sharma
15 [GO] 2021―Aug―06 Current perspective of COVID-19 on neurology: A mechanistic insight Rajesh Kumar, Seetha Harilal, Leena K Pappachan, P R Roshni, Bijo Mathew
16 [GO] 2021―Aug―05 Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes Nawal Helmi, Dalia Alammari, Mohammad Mobashir
17 [GO] 2021―Jul―12 COVID-19 candidate genes and pathways potentially share the association with lung cancer Afnan M. Alnajeebi, Hend F.H. Alharbi, Walla Alelwani, Nouf A. Babteen, Wafa Alansari, Ghalia Shamlan, Areej A. Eskandrani
18 [GO] 2021―Jun―02 Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2 Subhamoy Biswas, Smarajit Manna, Tathagata Dey, Shreyans Chatterjee, Sumanta Dey
19 [GO] 2021―Feb―04 An Urgent Industrial Scheme both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-Viral API for Treatment of COVID-19 Akbar Dadras, Mohammad Amin Rezvanfar, Abolghasem Beheshti, Sedigheh Sadat Naeimi, Seyyed Amir Siadati
20 [GO] 2020―Nov―24 Catechin Derivatives as Inhibitor of COVID-19 Main Protease (Mpro): Molecular Docking studies unveils an opportunity against CORONA Muhammad Nouman Arif
21 [GO] 2020―Nov―11 In-silico analysis of angiotensin converting enzyme 2 (ACE2) of livestock, pet and poultry animals to determine its susceptibility to SARS-CoV- 2 infection Aman Kumar, Anil Panwar, Kanisht Batra, Sachinandan Dey, Sushila Maan
22 [GO] 2020―Nov―11 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Acharya Balkrishna, Subarna Pokhrel, Anurag Varshney
23 [GO] 2020―Nov―06 A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2 Alamgir Hossain
24 [GO] 2020―Nov―03 Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation Zhenjie Zhuang, Xiaoying Zhong, Huanhuan Zhang, Huiqi Chen, Boxiang Huang, Dongqun Lin, Junmao Wen
25 [GO] 2020―Oct―27 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu, Xiaomin Wu, Jiayi Ren, Xiaochun Zhang, Yueming Wang, Chengming Li, et al. (+6)
26 [GO] 2020―Oct―01 Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: A data mining Approach LiWei Yin, YaCen Gao, ZiPing Li, MengYu Wang, KaiXin Chen
27 [GO] 2020―Sep―15 In silico modeling of small molecule carboxamides as inhibitors of SARS-CoV 3CL protease: An approach towards combating COVID-19 Pathan Mohsin Khan, Vinay Kumar, Kunal Roy
28 [GO] 2020―Sep―03 Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach Ashish Shah, Vaishali Patel, Bhumika Parmar
29 [GO] 2020―Aug―30 Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19) Raghvendra Dubey, Kushagra Dubey
30 [GO] 2020―Aug―24 The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking Sisir Nandi, Mohit Kumar, Mridula Saxena, Anil Kumar Saxena
31 [GO] 2020―Aug―21 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation Uma Sankar Gorla, GSN Koteswara Rao, Uma Sankar Kulandaivelu, Rajasekhar Reddy Alavala, Siva Prasad Panda
32 [GO] 2020―Aug―19 Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam, Sushil K. Chaudhary, Shashikant Singh, Anshul Shakya
33 [GO] 2020―Aug―14 Molecular Docking and Virtual Screening based prediction of drugs for COVID-19 Sekhar Talluri
34 [GO] 2020―Aug―08 Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy Mingzhu Wang, Deyu Fu, Lei Yao, Jianhua Li
35 [GO] 2020―Aug―05 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening Samir Chtita, Assia Belhassan, Adnane Aouidate, Salah Belaidi, Mohammed Bouachrine, Tahar Lakhlifi
36 [GO] 2020―Jul―29 Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection? Mustafa Çelebier, İbrahim Celalettin Haznedaroğlu
37 [GO] 2020―Jul―27 Viral Evolution will Automatically Resolve COVID-19 Pandemic Deepak Sharma
38 [GO] 2020―Jul―16 Doctoral Degree Surplus and Dwindling Quality: A Perilous Blend for Young Scientists in Tackling COVID-19 Like Pandemics Deepak Sharma
39 [GO] 2020―Apr―08 Perspective on the COVID-19 Coronavirus Outbreak Gerald H. Lushington
 [1] 

39 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec